新型1-取代-2-(1′,3′-二氧五环-4′-基)苯并咪唑的合成

以地沟油水解副产物甘油和多聚甲醛为原料,经醇醛缩合和次氯酸钠催化氧化反应制得1,3-二氧杂环戊-4-酸(DIC); DIC与邻苯二胺或其衍生物进行酰胺化-环化反应高效地合成了3种新型的1-取代-2-(1′,3′-二氧五环-4′-基)苯并咪唑类化合物,其结构经UV-Vis, ¹H NMR, ¹³C NMR, IR和GC-MS表征。     

5,5′-二甲基-2,2′-二茚满-1,1′,3,3′-四酮的合成及结构表征

本文以4-甲基邻苯二甲酸酐为原料, 成功地合成了5,5′-二甲基-2,2′-二茚满-1,1′,3,3′-四酮(2). 通过元素分析、核磁共振、红外光谱及质谱等测试手段, 确定了化合物2的结构与存在形式, 通过ESR测试发现化合物2具有顺磁性.     

新型螺[氧化吲哚-3,3′-吡唑]-5′-二氟甲基-4′-甲酸酯类化合物的合成

以原位生成的二氟甲基重氮甲烷（CF₂HCHN₂）与靛红衍生的3-烯基氧化吲哚为原料,通过[3+2]环加成反应和1,3-H迁移过程,合成了3种结构新型的螺[氧化吲哚 3,3′-吡唑]-5′-二氟甲基-4′-甲酸酯类化合物,收率41~68%, dr 91: 9~99 : 1,其结构经¹H NMR, ¹³C NMR, ¹⁹F NMR和HR-MS(ESI-TOF)表征。并通过单晶X-射线单晶衍射确定其相对构型。     

(±)-3,5-二羟基-7,4′-二甲氧基二氢黄酮醇和(±)-3,5,7-三羟基-4′-甲氧基二氢黄酮醇的全合成

3,5 -二羟基 - 7,4′-二甲氧基二氢黄酮醇 ( 1 )从 Cephalanthus spathelliferus中分离得到后 [1] ,又在H aplopappus bayahuen[2 ] 和 L annea coromandelica[3] 等植物中被发现 ,在印度一直被用于治疗象皮病、阳痿、溃疡、阴道炎、口臭、痢疾和风湿病等 . 3,5 ,7-三羟基 - 4′-甲氧基二氢黄酮醇 ( 2 )首次从 Prunusdonestica[4 ] 中分离出来后 ,又从 Salix caprea L.,Brazilian propolis中得到 .研究表明 ,该化合物具有抗菌、抗肿瘤活性 .我们用与文献 [5 ]类似的方法以 2 ,4,6-三羟基苯乙酮和茴香醛为起始原料 ,经选择性保护、缩合、…     

3-(1′-烃氧亚氨基)乙基-4-羟基吡咯啉-2-酮类衍生物的合成与生物活性

以氨基酸乙酯为原料合成8种3-乙酰基-4-羟基吡咯啉-2-酮的类似物A, A与3种烃氧基胺盐酸盐反应合成了20个肟醚类衍生物3-(1'-烃氧亚氨基)乙基-4-羟基吡咯啉-2-酮(B), 其结构经 1H NMR, MS, IR和元素分析表征. 初步生物活性测定结果表明合成的化合物B具有一定的除草活性和抑制真菌活性.     

2,2′-联咪唑合成的改进方法

优化了传统合成及提纯2,2＇-联咪唑的方法,使实验步骤缩减,并使产率和纯度有较大提高。     

区域选择性Michael/Aldol串联反应合成新型1′-茚醇拼接3-氧化吲哚类化合物

以3-烯烃氧化吲哚为起始原料,甲苯为溶剂,与丙二腈或腈基乙酸乙酯发生区域选择性Michael/Aldol串联反应,合成了6个新型的1′-茚醇拼接3-氧化吲哚类化合物,收率73%~90%, dr高达10/1,其结构经¹H NMR, ¹³C NMR和HR-MS（ESI-TOF）表征。     

氯化亚锡还原法合成4′-氨基黄体酮类苯亚甲基衍生物

以黄体酮为原料,合成了4′-硝基苯亚甲基衍生物3,将其在SnCl2·2H2O/HCl体系中还原后得4′-氨基苯亚甲基衍生物4。 还原时以乙酸乙酯为溶剂,还原剂SnCl2为底物5倍化学计量时产率达74%,为甾类氨基衍生物的合成提供了一种便利方法。     

β-L-2’-脱氧胞苷的合成

β-L-2’-脱氧胞苷为重要的医药中间体。以2’-脱氧-L-核糖和胞嘧啶为起始原料，通过甲苷化、酯化、氯代、水解脱保护基等步骤，以49.7%的收率合成了β-L-2’-脱氧胞苷，HPLC纯度达99.9%。产物结构经¹H NMR, ¹³C NMR和MS确证。      

α-卤代腙与α-异氰酸酯反应合成4-腙基-2-异氰基丁酸酯类化合物

α-卤代腙与α-异氰酸酯在三乙胺作用下反应，生成4-腙基-2-异氰基丁酸酯类化合物。通过优化合成工艺，确定最佳反应条件为：α-卤代腙（1.0 eq.），α-异氰酸酯（1.2 eq.），三乙胺（1.2 eq.），二氯甲烷作溶剂，反应24 h。在此条件下进行了底物普适性研究，以高达79%的收率得到一系列具有潜在价值的4-腙基-2-异氰基丁酸酯类化合物，产物结构经¹H NMR，¹³C NMR和MS（ESI）确证。      

Syntheses and properties of complexes with bis(2,2′-bipyridyl)ruthenium(II) moieties coordinated to 4,4′:2′,2′′:4′′,4′′′-quaterpyridinium ligands

Eleven new complexes of the form cis-[Ru^II(bpy)₂(L^A)]⁴⁺ (bpy = 2,2′-bipyridyl; L^A = a pyridinium-substituted bpy derivative) have been prepared and isolated as their PF₆⁻ salts. Characterisation involved various techniques including ¹H NMR spectroscopy and MALDI mass spectrometry. The UV-Vis spectra show intense intraligand π → π^∗ absorptions and metal-to-ligand charge-transfer (MLCT) bands with two distinct maxima in the visible region. Small shifts in the MLCT bands correlate with the electron-withdrawing strength of the ligand L^A. Cyclic voltammograms show quasi-reversible or reversible Ru^III/II oxidation waves, and two or more ligand-based reductions with varying degrees of reversibility. The variations in the redox potentials correlate with changes in the structure of L^A, and also with the MLCT energies. Differential pulse voltammetry allows the first reduction process for two of the complex salts to be resolved into two peaks. Single-crystal X-ray structures have been solved for three of the new complex salts and also for a pro-ligand salt. Two carboxylate-functionalised compounds have been tested as photosensitizers on TiO₂-coated electrodes, but show only negligible efficiencies, in accord with expectations.     

Synthesis of 2′,3′-dideoxy-6′,6′-difluoro-3′-azanucleosides

The straightforward synthesis of four novel 2′,3′-dideoxy-6′,6′-difluoro-3′-azanucleosides 1a-d is described. Efficient construction of the fluorine-containing pyrrolidine ring through two different ways and installation of pyrimidine rings using the amino groups in the intermediates 12, 26 were the key steps of our synthesis.     

3′-Selective modification of a 4′,5′-didehydro-5′-deoxy-2′,3′-epoxyuridine using nucleophiles

1-(2,3-Anhydro-5-deoxy-4,5-didehydro-α-l-erythro-pent-4-enofuranosyl)uracil 4 was obtained by the treatment of 5′-iodo-2′,3′-epoxyuridine 5 with LiHMDS in excellent yield. The pyrimidine nucleoside 4 possesses quite unique vinyl epoxide moiety within the molecules. The reactions of 4 with a variety of nucleophiles gave 3′-substituted pyrimidine nucleosides without the formation of the corresponding 2′-substituted isomers. In the case of NaN₃ or PhSH, the corresponding 5′-adduct was obtained as a minor product together with the expected 3′-adduct.     

Straightforward synthesis of 3′-deoxy-3′,4′-didehydronucleoside-5′-aldehydes via 2′,3′-O-orthoester group elimination: a simple route to 3′,4′-didehydronucleosides

Straightforward, high-yielding syntheses of 3′-deoxy-3′,4′-didehydronucleoside-5′-aldehydes and 3′-deoxy-3′,4′-didehydronucleosides starting from 2′,3′-O-orthoester derivatives of ribonucleosides are described.     

Synthesis of a series of novel 2′,3′-dideoxy-6′,6′-difluoro-3′-thionucleosides

A series of novel 2′,3′-dideoxy-6′,6′-difluoro-3′-thionucleosides 1a-d, analogues of 3TC that has high biological activities against HIV and HBV, have been synthesized from the gem-difluorohomoallyl amine 7 in a straightforward fashion. Our synthesis featured the construction of thiofuranose skeleton through ring closure of key intermediates and installation of pyrimidine ring with amino group in compounds 13a,b.     

Novel and efficient syntheses of 3′,5′-diamino derivatives of 2′,3′,5′-trideoxycytidine and 2′,3′,5′-trideoxyadenosine. Protonation behavior of 3′,5′-diaminonucleosides

High yielding synthetic routes to 3′,5′-diamino-2′,3′,5′-trideoxycytidine and 3′,5′-diamino-2′,3′,5′-trideoxyadenosine are described. In addition, the protonation behavior of 3′,5′-diamino-2′,3′,5′-trideoxycytidine, 3′,5′-diamino-2′,3′,5′-trideoxyadenosine, 3′,5′-diamino-3′,5′-dideoxythymidine, and 3′,5′-diamino-2′,3′,5′-trideoxyuridine has been studied by means of pH-metric measurements and NMR spectroscopy. The ionization constants and the sequence of protonation sites have been determined.     

Synthesis of 3′-azido-4′-ethynyl-3′,5′-dideoxy-5′-norarabinouridine: a new anti-HIV nucleoside analogue

3′-Azido-4′-ethynyl-3′,5′dideoxy-5′-norarabinouridine 10 was synthesized from commercial uridine 1 in which the key step is the opening of protected 2′,3′-epoxyuridine derivative 7 by sodium azide and the hydroxymethyl at 4-position of the ribose ring are replaced by ethynyl group.     

Enantiospecific synthesis of 5′,5′,5′-trifluoro-5′-deoxyneplanocin A

(−)-(1S,4R)-4-Hydroxy-2-cyclopenten-1-yl acetate provided a convenient entry point for a 12-step chiral preparation of 5′,5′,5′-trifluoro-5′-deoxyneplanocin A.     

Synthesis and anti-HIV activities of phosphate triester derivatives of 3′-fluoro-2′,3′-dideoxythymidine and 3′-azido-2′,3′-dideoxythymidine

Fatty acyl-glycol phosphate triester conjugates of 3′-fluoro-2′,3′-dideoxythymidine (FLT) were prepared in three steps from the reaction of diisopropylphoramidous dichloride with fatty acyl-substituted glycols, followed by a coupling reaction with FLT and oxidation with tert-butyl hydroperoxide (t-BuOOH). Additionally, a number of fatty alcohols were reacted with diisopropylphoramidous dichloride to produce the phosphitylating intermediates, which underwent coupling reactions with 3′-azido-2′,3′-dideoxythymidine (AZT) and FLT followed by oxidation with t-BuOOH to yield fatty alcohol phosphate triester derivatives of AZT and FLT.